Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study.

ABSTRACT:

Aims

This study examined rates of metabolic/bariatric surgery (MBS) among adults with type 2 diabetes and obesity (T2D + O). The study also compared glucose-lowering medication (GLM) use, costs, comorbidities and medical events for individuals with T2D + O who underwent MBS (cases) to those who did not have MBS (controls).

Materials and methods

Optum Market Clarity US data were used. Annual rates of MBS were examined for adults with T2D + O. MBS cases were matched 1:1 without replacement to controls based upon patient demographics and baseline body mass index (BMI) and followed for a 3-year post-period. Differences in outcomes were examined between cases and controls.

Results

From 2013 through 2022, 0.5% of adults with T2D + O (0.3%, 0.5% and 0.9% for class 1-3 obesit

SUBMITTER: Boye KS 

PROVIDER: S-EPMC12673424 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature